- VENUS REMEDIES
VENUS REMEDIES Share Price
NSE: VENUSREM
|BSE: 526953
|Pharmaceuticals
₹355.60
+₹0.55 (0.15%) Last updated on 23 May, 2025 | 15:55 ISTVENUS REMEDIES Overview
Market cap  ₹475 Crs | Open ₹359.45 | Prev. Close ₹355.05 |
Circuit range ₹426.70 - ₹284.50 | Day range ₹351.10 - ₹361.25 | Year range ₹270.25 - ₹427.90 |
Volume 22,355 | Avg. traded ₹356.49 | Revenue (12m) ₹648 Crs |
About VENUS REMEDIES
Venus Remedies Limited is a research-driven pharmaceutical company. The Company is a global injectable manufacturer. It manufactures products catering to critical care segments such as antimicrobial resistance, anti-cancer, Anti-infective, Neurology, Skin and Wound Care, and Pain Management. With a diverse portfolio of products, the Company is dedicated to revolutionizing patient care through its specialized therapeutic segments such as anti-infective (antibiotics), oncology, neurology, pain management, and skin & wound care. The Company operates only in one business segment: Pharmaceutical Formulation and is engaged in manufacturing and trading of medicines. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, and others. It has three manufacturing facilities: Panchkula and Baddi in India and Werne in Germany.
VENUS REMEDIES Share Price Chart
Please wait...
VENUS REMEDIES Key Indicators
P/E ratio 13.63 | P/B ratio 0.8 | ROE 6.18% |
ROCE 8.77% | Dividend yield -- | Debt/Equity ratio 0.08 |
EPS 22.82 |
Investment Checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst Ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
VENUS REMEDIES Financial Ratios
Operating profit margin12.55% | Net profit margin5.3% |
ROE6.18% | ROA4.88% |
ROCE8.77% |
Quick ratio3.34 | Current ratio4.96 |
Interest coverage0 | Asset turnover0.92 |
Debt to Equity0.08 |
P/E ratio13.63 | P/B ratio0.8 |
EV / EBITDA5.64 | |
Dividend yield0% |
Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-24 | ₹601.45 | ₹71.18 | ₹28.49 |
Mar-23 | ₹555.51 | ₹70.35 | ₹26.57 |
Mar-22 | ₹600.18 | ₹70.42 | ₹40.72 |
Mar-21 | ₹548.12 | ₹73.41 | ₹61.77 |
Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-24 | ₹-7.21 | ₹-1.08 | |
Mar-23 | ₹-50.83 | ₹-0.57 | |
Mar-22 | ₹-16.73 | ₹-9.48 | |
Mar-21 | ₹-162.24 |
Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-24 | ₹626.82 | ₹139.27 |
Mar-23 | ₹601.08 | ₹140.74 |
Mar-22 | ₹579.14 | ₹138.69 |
Mar-21 | ₹555.85 | ₹155.57 |
VENUS REMEDIES Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
23-May-25 | ₹359.45 | ₹355.60 | |
22-May-25 | ₹355.00 | ₹355.05 | |
21-May-25 | ₹335.45 | ₹349.90 | |
20-May-25 | ₹342.65 | ₹333.75 | -1.14% |
19-May-25 | ₹349.00 | ₹337.60 | -1.50% |
16-May-25 | ₹328.80 | ₹342.75 | |
15-May-25 | ₹320.90 | ₹325.45 | |
14-May-25 | ₹316.70 | ₹316.55 |
Stocks Similar to VENUS REMEDIES
Stock Name | Price | Change % |
|---|---|---|
| ANG LIFESCIENCES INDIA LIMITED | ₹29.41 | -₹0.45 (-1.51%) |
| ANUH PHARMA LIMITED | ₹201.00 | -₹10.44 (-4.94%) |
| BETA DRUGS LIMITED | ₹1,720.00 | -₹49.90 (-2.82%) |
| Ind Swift Laboratories | ₹72.20 | -₹1.58 (-2.14%) |
| Nectar Lifesciences | ₹23.71 | -₹0.19 (-0.79%) |
| SHREE GANESH REMEDIES LIMITED | ₹615.90 | +₹8.70 (1.43%) |
| Windlas Biotech | ₹917.40 | -₹53.55 (-5.52%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| Indian Energy Exchange | ₹195.03 | +₹0.20 (0.10%) |
| ITC | ₹436.30 | +₹10.20 (2.39%) |
| JIO FIN SERVICES LTD | ₹281.75 | +₹7.20 (2.62%) |
| Suzlon | ₹62.21 | +₹1.20 (1.97%) |
| Tata Motors | ₹718.25 | +₹0.80 (0.11%) |
| Tata Power | ₹402.05 | +₹6.45 (1.63%) |
| Tata Steel | ₹162.97 | +₹1.68 (1.04%) |
| Vodafone Idea | ₹6.76 | +₹0.01 (0.15%) |
| Wipro | ₹247.36 | +₹1.42 (0.58%) |
| YES Bank | ₹21.15 | +₹0.18 (0.86%) |
VENUS REMEDIES News
Livemint
Venus Remedies stock jumps over 14% to 8-week high
CNBC Television
Venus Remedies gains 4%
CNBC Television
Venus Remedies gains nearly 3%
Moneycontrol
Venus Remedies shares rise 3% as Moldova GMP nod paves way for East Europe
CNBC
Venus Remedies gains after receiving good manufacturing certification
CNBC
Venus Remedies surges nearly 8%
CNBC Television
Venus Remedies surges nearly 8%
FAQs on VENUS REMEDIES
What is the share price of VENUS REMEDIES today?
VENUS REMEDIES share price is ₹ 355.60 as on 23 May, 2025 | 15:55 IST.
What are the high & low stock price of VENUS REMEDIES today?
VENUS REMEDIES stock price hit a high of ₹ 361.25 and low of ₹ 351.10 as on 23 May, 2025 | 15:55 IST.
What is the market cap of VENUS REMEDIES?
The market cap of VENUS REMEDIES is ₹ 475.33 Crores as on 23 May, 2025 | 15:55 IST.
What are the the 52-week high and low share prices of VENUS REMEDIES stock on the NSE?
52-week high stock Price of VENUS REMEDIES is ₹ 427.90 and Low Price is ₹ 270.25 as on 23 May, 2025 | 15:55 IST.
What are the stock symbols of VENUS REMEDIES?
The stock symbol of VENUS REMEDIES is NSE: VENUSREM on the NSE, BSE: 526953 on the BSE, and the ISIN is INE411B01019.
Can I buy VENUS REMEDIES shares on Holidays?
No, shares of VENUS REMEDIES or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell VENUS REMEDIES shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of VENUS REMEDIES?
The PE and PB ratio of VENUS REMEDIES is 13.63 and 0.8 respectively, as on 23 May, 2025 | 15:55 IST.
What are the returns on VENUS REMEDIES shares?
The historical returns for VENUS REMEDIES shares are 17.78 for 1 year, 45.57 for 3 year and 572.44 for 5 year.